PATCH-Trauma Trial Presentation

1

Introduction

00:00 • 3min

2

The Benefits of Tranexamic Acid in Surgery

02:58 • 2min

3

Tranexamic Acid and the Victorian State Trauma System

05:20 • 3min

4

Transexamic Acid in Trauma

08:02 • 2min

5

The Equipois Trial: A Pragmatic RCT

09:49 • 2min

6

The Co-Score for Acute Traumatic Quagulopathy

12:13 • 3min

7

The Effects of TBI on Primary Outcomes

14:54 • 4min

8

How to Recruit for a Trauma Trial

18:38 • 2min

9

How to Improve Bandwidth Satisfaction in Trauma Teams

21:03 • 2min

10

The Randomisation of Trauma Patients

23:26 • 4min

11

The Effect of Tranexamic Acid on Neurologic Outcomes

27:08 • 5min

12

The Effects of Occlusion on Functional Outcomes

32:08 • 1min

13

The DSMC's Patch Trial

33:25 • 2min

14

Can Channelic Acid Be Delivered in a Mature Developed Organised High Income Trauma System?

35:42 • 4min

15

The Role of Tranexamic Acid in Trauma-Induced Coagulation

39:21 • 4min

16

Tranexamic Acid in Low-Income Settings

43:05 • 3min

17

The Effects of the Coast Score on Mortality and Ghost Outcomes

46:25 • 5min

18

The Effects of TXA on Functional Outcomes

51:44 • 5min

19

Tranexamic Acids: Can We Pick Patients That Might Do Better?

56:36 • 3min

20

The Effects of TXA on Cardiovascular Function

59:10 • 3min

21

The Effect of Tranexamic Acid on Neurological Outcomes

01:01:58 • 2min

22

The Role of Long Term Outcome Measures in Neurological Injury

01:04:05 • 2min

23

The Effects of Tranisabic Acid on Functional Recovery

01:05:37 • 3min

24

The Transamic Acid TXA Trial

01:08:55 • 5min

25

The Effect of Blood Product Use on Outcomes in TBI and Hemorrhagic Stomach

01:14:00 • 2min

26

The Accommodation With Missing Data

01:16:26 • 4min

27

The Importance of Long-Term Outcomes

01:20:06 • 4min